Australia markets closed

JW Pharmaceutical Corporation (001067.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
59,000.00-500.00 (-0.84%)
At close: 03:30PM KST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
660,661,391
748,526,708
684,351,099
606,584,945
547,335,708
Cost of revenue
395,942,795
412,984,312
396,396,562
372,208,611
369,810,084
Gross profit
264,718,597
335,542,396
287,954,538
234,376,333
177,525,624
Operating expenses
Research development
25,914,024
33,671,364
33,736,273
19,883,612
22,943,262
Selling general and administrative
128,225,241
152,639,104
126,737,797
115,338,221
92,519,417
Total operating expenses
218,177,578
234,625,757
225,175,477
203,176,484
178,848,606
Operating income or loss
46,541,019
100,916,639
62,779,061
31,199,849
-1,322,982
Interest expense
10,523,888
12,561,689
9,386,791
7,336,662
7,587,145
Income before tax
37,544,877
54,836,450
45,361,952
20,532,661
-13,205,175
Income tax expense
25,857,763
16,406,190
15,509,392
21,974,114
2,070,295
Income from continuing operations
11,687,114
38,430,260
29,852,560
-1,441,453
-15,275,470
Net income
12,130,479
37,006,334
31,891,679
-967,850
-15,241,283
Net income available to common shareholders
12,130,479
37,006,334
31,891,679
-967,850
-15,241,283
Basic EPS
1.02k
-
1.24k
-39.03
-606.22
Diluted EPS
1.02k
-
1.24k
-39.03
-606.22
Basic average shares
21,647
-
25,675
24,801
25,142
Diluted average shares
21,647
-
25,675
24,801
25,142